Skip to main content

Table 3 Percentage of flea-free primary dogs (dogs with ≥ 5 fleas on day 0)

From: Clinical efficacy and safety of a single administration of fluralaner injectable suspension (BRAVECTO® injectable) vs. monthly administration of oral afoxolaner (NexGard®) in dogs for tick and flea control over one year under European field conditions

Visit (study day)

Flea-free dogs

P-value

Lower 97.5% one-sided confidence interval

Fluralaner injection (n = 128)

Afoxolaner oral (n = 72)

 

V2 (14)

120 (93.8%)

67 (93.1%)

0.0019

−0.0653

V3 (28)

125 (97.7%)

70 (97.2%)

0.0003

−0.0551

V4 (56)

124 (96.9%)

67 (93.1%)

 < 0.0001

−0.0310

V5 (84)

127 (99.2%)

69 (95.8%)

 < 0.0001

−0.0279

V6 (112)

127 (100.0%)a

71 (98.6%)

 < 0.0001

−0.0416

V7 (224)

127 (99.2%)

71 (98.6%)

 < 0.0001

−0.0494

V8 (280)

127 (99.2%)

72 (100.0%)

0.0003

−0.0598

V9 (336)

81 (95.3%)

70 (97.2%)

0.0045

−0.0798

V10 (365)

124 (96.9%)

72 (100.0%)

0.0048

−0.0832

  1. aAssessment from 127 dogs